Abstract: Techniques for managing accounts are provided. An access management system may check out credentials for accessing target systems. For example a user may receive a password for a period of time or until checked back in. Access to the target system may be logged during this time. Upon the password being checked in, a security account may modify the password so that the user may not log back in without checking out a new password. Additionally, in some examples, password policies for the security account may be managed. As such, when a password policy changes, the security account password may be dynamically updated. Additionally, in some examples, hierarchical viewing perspectives may be determined and/or selected for visualizing one or more managed accounts. Further, accounts may be organized into groups based on roles, and grants for the accounts may be dynamically updated as changes occur or new accounts are managed.

Abstract: A system manages information exchanges between components of the system so that information is provided in a format expected by each particular component. In a specific implementation, a translation service provider intercepts information exchanges between client and data sources or data services and translates of converts software identifiers (e.g., UUIDs or GUIDs) as needed so that the client or data source can properly process the data. For example, a client may use GUIDs in a first format, and when information is requested is presented using a GUID in a second format, different from the first, the translation service provider translates a GUID to the first format. The translation service provider may be transparent to the other components of the system.

Abstract: The invention provides isolated or purified nucleic molecules consisting of a nucleotide sequence encoding human transductin-1 (TDC1), such as SEQ ID NO: 1. The invention also provides vectors comprising the isolated or purified nucleic acid sequences and cells comprising such vectors.

Abstract: A system manages information exchanges between components of the system so that information is provided in a format expected by each particular component. In a specific implementation, a translation service provider intercepts information exchanges between client and data sources or data services and translates of converts software identifiers (e.g., UUIDs or GUIDs) as needed so that the client or data source can properly process the data. For example, a client may use GUIDs in a first format, and when information is requested is presented using a GUID in a second format, different from the first, the translation service provider translates a GUID to the first format. The translation service provider may be transparent to the other components of the system.

Abstract: The invention provides an isolated or purified nucleic acid molecules consisting essentially of the nucleotide sequence encoding either transductin-1 (TDC1) or transductin-2 (TDC2), related and derivative nucleic acid molecules vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

Abstract: The invention provides methods of detecting hearing loss or a predisposition to hearing loss in an animal, which comprises detecting at least one mutation in a gene encoding transduction-1 (TDC1) in a test sample obtained from the animal. The invention also provides a method of determining the level of nucleic acid comprising a wild-type TDC1 gene and/or a mutant TDC1 gene in a test sample obtained from an animal.

Abstract: The invention provides an isolated or purified nucleic acid molecule consisting essentially of the nucleotide sequence encoding transductin-2 (TDC2), related and derivative nucleic acid molecules, vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

Abstract: The invention provides an isolated or purified nucleic acid molecule consisting essentially of the nucleotide sequence encoding transductin-2 (TDC2), related and derivative nucleic acid molecules, vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

Abstract: The invention provides an isolated or purified nucleic acid molecules consisting essentially of the nucleotide sequence encoding either transductin-1 (TDC1) or transductin-2 (TDC2), related and derivative nucleic acid molecules, vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.

Abstract: An adjustable optical device including an optical element, a housing having an adjusting post fixed thereto, the optical element mounted to the housing, the housing adjusting post having a plane of movement, and an adjustment mechanism, the housing flexibly connected to the adjustment mechanism, the adjustment mechanism comprising a moving adjusting member in sliding engagement with the housing adjusting post, one of the adjusting member and the housing adjusting post comprising a wedge. The housing adjusting post is urged into movement in its plane of movement in response to relative movement between the adjusting member and the adjusting post, whereby the orientation of the optical element relative to the adjusting mechanism is adjusted by movement of the moving adjusting member.

Abstract: An adjustable optical device including an optical element, a housing having an adjusting post fixed thereto, the optical element mounted to the housing, the housing adjusting post having a plane of movement, and an adjustment mechanism, the housing flexibly connected to the adjustment mechanism, the adjustment mechanism comprising a moving adjusting member in sliding engagement with the housing adjusting post, one of the adjusting member and the housing adjusting post comprising a wedge. The housing adjusting post is urged into movement in its plane of movement in response to relative movement between the adjusting member and the adjusting post, whereby the orientation of the optical element relative to the adjusting mechanism is adjusted by movement of the moving adjusting member.

Abstract: The invention concerns novel hybrid pesticidal toxins. These toxins are expressed as the fusion protein of a chimeric gene. Specifically exemplified is a novel B.t. hybrid toxin. These novel toxins have increased toxicity against target pests. The invention also concerns a process for preparing a hybrid virus having an altered insect host range.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository. The microbe is now known as B. thuringiensis strain san diego.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository. The microbe is now known as B. thuringiensis strain san diego.

Abstract: The toxin gene encoding a protein toxic to beetles of the order Coleoptera, named M-7, has been cloned and expressed. M-7 is a novel Bacillus thuringiensis strain which has been deposited with a recognized culture repository. The microbe is now known as B. thuringiensis strain san diego.

Abstract: The present invention provides a method for manufacturing an automobile sunvisor, wherein a pair of overcoatings for the sunvisor, the rear surface of which is respectively covered with a layer of thermoplastic resin, is pressure-welded between an upper electrode member and a lower electrode member and cut at the same position without displacement, thus forming no protruding welded portion in the periphery of the sunvisor. Moreover, the pair of the overcoatings can be securely welded to each other without any particular portion for welding prepared in the overcoatings because the thermoplastic resin is melted inside the sealed portion of the pair of overcoatings during the pressure-welding.